Cargando…
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
At the time of writing, FIND has listed four CE-marked SARSCoV-2 antigen tests. We evaluated the recently CE-approved rapid POCT SD-Biosensor for SARS-CoV-2 nucleoprotein detection in nasopharyngeal secretions from 330 patients admitted to the Emergency Room for a suspect of COVID-19 and travelers r...
Autores principales: | Cerutti, Francesco, Burdino, Elisa, Milia, Maria Grazia, Allice, Tiziano, Gregori, Gabriella, Bruzzone, Bianca, Ghisetti, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522649/ https://www.ncbi.nlm.nih.gov/pubmed/33053494 http://dx.doi.org/10.1016/j.jcv.2020.104654 |
Ejemplares similares
-
SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic
por: Burdino, Elisa, et al.
Publicado: (2022) -
Rapid antigen tests for SARS-CoV-2
por: Liu, Michael, et al.
Publicado: (2021) -
Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands
por: Iglὁi, Zsὁfia, et al.
Publicado: (2021) -
Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms
por: Flinck, Heini, et al.
Publicado: (2022) -
Testing for responses to the wrong SARS-CoV-2 antigen?
por: Rosadas, Carolina, et al.
Publicado: (2020)